Variant report
Variant | esv18316 |
---|---|
Chromosome Location | chr13:64935358-64943378 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117631890 | chr13:64941614-64941615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201790713 | chr13:64941616-64941617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543688145 | chr13:64941632-64941633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373668095 | chr13:64941661-64941662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370591912 | chr13:64941695-64941696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141130993 | chr13:64941702-64941703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1417188 | chr13:64941705-64941706 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs533197374 | chr13:64941712-64941713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373710496 | chr13:64941721-64941722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114969568 | chr13:64941775-64941776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569882352 | chr13:64941777-64941778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530818793 | chr13:64941792-64941793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574829177 | chr13:64941795-64941796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150909529 | chr13:64941796-64941797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534711086 | chr13:64941807-64941808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9571182 | chr13:64941831-64941832 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs61949915 | chr13:64941833-64941834 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs571916550 | chr13:64941895-64941896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546489033 | chr13:64941913-64941914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138524392 | chr13:64941922-64941923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144069871 | chr13:64941924-64941925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189398934 | chr13:64941926-64941927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182248371 | chr13:64941935-64941936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532104384 | chr13:64941949-64941950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371017631 | chr13:64941962-64941963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541219435 | chr13:64941972-64941973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147307835 | chr13:64941990-64941991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533232897 | chr13:64942031-64942032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76888340 | chr13:64942047-64942048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78345095 | chr13:64942073-64942074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9598776 | chr13:64942083-64942084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530736967 | chr13:64942096-64942097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140909375 | chr13:64942129-64942130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561073266 | chr13:64942176-64942177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186038123 | chr13:64942185-64942186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540877052 | chr13:64942211-64942212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190838526 | chr13:64942230-64942231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372075987 | chr13:64942250-64942251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs4261411 | chr13:64942263-64942264 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs550324651 | chr13:64942280-64942281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568785429 | chr13:64942309-64942310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200362630 | chr13:64942326-64942327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564027112 | chr13:64942333-64942334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374012364 | chr13:64942336-64942337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537351619 | chr13:64942343-64942344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183031921 | chr13:64942355-64942356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573995280 | chr13:64942390-64942391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61949916 | chr13:64942404-64942405 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs114701625 | chr13:64942426-64942427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370631442 | chr13:64942429-64942430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64941600-64942000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr13:64942000-64942600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr13:64942200-64942600 | Enhancers | HMEC | breast |
4 | chr13:64942600-64944200 | Weak transcription | HMEC | breast |
5 | chr13:64943200-64943600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |